Discussion     ‘ myeloma ’


Transplants and Risk Adapted Maintenance in Myeloma Treatment


The treatment paradigm for myeloma patients has changed in the last decade with important advancements such as proteasome inhibitors, IMiDS, antibodies and risk-adapted maintenance. How ...

Jan. 4, 2019, 11 a.m. 1 Listen

Inherited Gene Mutations in Myeloma and Role of Precision Medicine


Multiple Myeloma is the second most common cancer of the blood and is largely incurable. A recent study has found that a specific gene mutation ...

Aug. 30, 2018, 10 a.m. 4 Listen

Latest Advances in Myeloma Treatment: ASCO and EHA 2018 Highlights


The treatment field of Multiple Myeloma continues to move forward as novel agents and treatment combinations expand. Whether you are standard risk patient or belong ...

July 9, 2018, 10 a.m. 2 Listen

Multiple Myeloma: An Insight into Early Intervention and Personalized Therapies


Myeloma patients are definitely living longer. A decade ago the median survival was 3 to 4 years, while now it is in the range of ...

May 10, 2018, 6 p.m. 3 Listen

Myeloma 2017 - Year in Review with MMRF


The MMRF is pioneering precision medicine initiatives in multiple myeloma. This would help match patients to the most effective therapies based on their genetics and ...

Jan. 25, 2018, 1 p.m. 5 Listen